Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioControl Medical Ltd.

www.biocontrol-medical.com

Latest From Shanghai Celgen Bio-Pharmaceutical Co. Ltd.

Celltrion Gets Go-Ahead For Remsima Trials In China, Mulls JV

Celltrion has received approval to begin clinical trials of its biosimilar infliximab in China and also filed IND applications for other biosimilar products with the CFDA, accelerating plans to enter the world’s second biggest pharma market as it propels efforts for global leadership in the biosimilar space.

Commercial Companies

BMS Tests Virtual R&D Network In China For Orencia Deal With Simcere

BMS has been trying since 2012 to figure out a way to bring its first biologic product to China. Now, the company will partner with Simcere to hasten development of its $1.2 billion rheumatoid arthritis blockbuster Orencia.

BioPharmaceutical China

BMS Tests Virtual R&D Network In China For Orencia Deal With Simcere

BMS has been trying since 2012 to figure out a way to bring its first biologic product to China. Now, the company will partner with Simcere to hasten development of its $1.2 billion rheumatoid arthritis blockbuster Orencia.

BioPharmaceutical China

China’ Simcere To Sell Its 35% Stake In Shanghai Celgen

China’sSimcere Pharmaceutical Group plans to sell its 35% stake in Shanghai Celgen Bio-Pharmaceutical Co. Ltd. for $48 million, exiting a deal signed in 2009.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Cardiovascular
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • BioControl Medical Ltd.
  • Senior Management
  • Ehud Cohen, PhD, CEO
  • Contact Info
  • BioControl Medical Ltd.
    Phone: (972) 3 632 2126
    3 Geron St.
    P.O. Box 2713 Yehud, 56100
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register